Skip to main content

Closed

NUVB: Nuvation Bio Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin-105.0%

ROIC-27.9%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage-7.4×

Current ratio7.44×

Nuvation Bio Inc.

NUVBNew York Stock Exchange·USD·Closed

Nuvation Bio Inc.

NUVBNew York Stock Exchange·USD·Closed

$6.33

−5.52%

$6.33

−$0.37 (5.52%)

52W Range

55thpctl

Volume

0.61×avg

Mkt Cap

2.20BUSD

P/E

-14.9TTM

Div Yield

–ann

52W Range

55thpctl

Volume

0.61×avg

Market Cap

2.20BUSD

P/E Ratio

-14.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings